BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with ...
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...
New understanding of aggressive form of breast cancer paves the way for tests and treatments
Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to ...
I only had one tiny symptom – I never thought it was cancer
I only ever had one symptom; but I never thought it was breast cancer. It was the tiniest, most subtle thing. I used to do burlesque, and whenever I had a corset on, I’d notice a pinprick-size dimple ...